The retail pharmacy giant saw its revenue increase 8.3 percent in the first quarter and its pharmacy revenue increase by 4.2 percent, according to a May 6 news release.
Its earnings per share were $1.91 and total revenue was $66.8 billion in the first quarter. The company said it expects its 2020 earnings to be between $7.04 to $7.17 per share.
The pandemic caused more customers to order 90-day prescriptions, CVS said, causing its total pharmacy claims processed to increase by 12.4 percent.
CVS also plans to ramp up COVID-19 testing by opening 1,000 testing sites across the country.
Read the full earnings report here.
More articles on pharmacy:
Gilead gets FDA emergency use authorization for remdesivir
AmerisourceBergen offers to buy Walgreens’ drug wholesaling division
CVS says it will boost access to mental health services
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.